You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: October 14, 2024

RIMIFON Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Rimifon patents expire, and what generic alternatives are available?

Rimifon is a drug marketed by Roche and is included in one NDA.

The generic ingredient in RIMIFON is isoniazid. There are five drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the isoniazid profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Rimifon

A generic version of RIMIFON was approved as isoniazid by OMNIVIUM PHARMS on June 26th, 1997.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for RIMIFON?
  • What are the global sales for RIMIFON?
  • What is Average Wholesale Price for RIMIFON?
Summary for RIMIFON
Drug patent expirations by year for RIMIFON
Recent Clinical Trials for RIMIFON

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Assistance Publique - Hôpitaux de ParisPhase 2

See all RIMIFON clinical trials

US Patents and Regulatory Information for RIMIFON

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Roche RIMIFON isoniazid INJECTABLE;INJECTION 008420-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Roche RIMIFON isoniazid INJECTABLE;INJECTION 008420-003 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Roche RIMIFON isoniazid SYRUP;ORAL 008420-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.